Studies have shown that monitoring B-ALL patients at different timepoints using IGH, IGK (VK-KDE), TCRG, and TCRD gene rearrangements achieves acceptable sensitivity levels31. Here, TRGC1 is linked to acute lymphoblastic leukemia.